Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
3 hedge funds and large institutions have $960K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $679K | +$877K | +375,000 | New |
|
|
APU
2
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $280K | +$152K | +65,000 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | +$1.5K | +640 | New |
|
SGYPW Hedge Fund Activity: Q2 2013 in Review
3 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q2 2013, worth a combined $960K.
Buyers outnumbered sellers: 3 funds opened new SGYPW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $960K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q2 2013.
- 3 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q2 2013 and 0 closed out, a net change of +3 holders.
Based on aggregated 13F filings for Q2 2013.